Bernward Schoelkens

Title: Bernward Schoelkens: Innovator in Thrombogenic Disorder Identification

Introduction

Bernward Schoelkens is a notable inventor based in Kelkheim, Germany. He has made significant contributions to the field of medical diagnostics, particularly in identifying risks associated with thrombogenic disorders. With a total of three patents to his name, Schoelkens has demonstrated a commitment to advancing healthcare through innovative solutions.

Latest Patents

Schoelkens' latest patents focus on methods for identifying risks for thrombogenic disorders by determining the TAFI-Ile347 polymorphism. These inventions aim to identify risks for conditions such as atrial fibrillation, stroke, and coronary heart disease. His work includes methods for selecting patients at risk, identifying pharmaceuticals for therapy or prophylaxis, and producing medicaments and diagnostics utilizing the TAFI-Ile347 polymorphism.

Career Highlights

Schoelkens is currently employed at Sanofi-Aventis Deutschland GmbH, where he continues to contribute to medical research and innovation. His expertise in thrombogenic disorders has positioned him as a key figure in the development of diagnostic methods that can potentially save lives.

Collaborations

Throughout his career, Schoelkens has collaborated with notable colleagues such as Detlef Kozian and Stefan Schaefer. These partnerships have fostered an environment of innovation and have led to the successful development of his patented methods.

Conclusion

Bernward Schoelkens is a distinguished inventor whose work in identifying thrombogenic disorder risks has made a significant impact in the medical field. His contributions through patents and collaborations highlight the importance of innovation in healthcare.